Carboxy-terminus of CXCR7 regulates receptor localization and function

International Journal of Biochemistry and Cell Biology

Volumn 44, Issue 4, 2012, Pages 669-678

  Ray, Paramita ^a   Mihalko, Laura Anne ^a   Coggins, Nathaniel L ^a   Moudgil, Pranav ^a   Ehrlich, Anna ^a   Luker, Kathryn E ^a   Luker, Gary D ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

Bioluminescence; Chemokine; Chemokine receptor; Luciferase; Protein fragment complementation

Indexed keywords

BETA ARRESTIN 2; CHEMOKINE RECEPTOR CXCR7; DYNAMIN; LUCIFERASE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PLASMA MEMBRANE CALCIUM TRANSPORTING ADENOSINE TRIPHOSPHATASE;

ARTICLE; CARBOXY TERMINAL SEQUENCE; ENDOCYTOSIS; HUMAN; HUMAN CELL; PROTEIN FUNCTION; PROTEIN LOCALIZATION;

ARRESTINS; CELL LINE, TUMOR; CELL MEMBRANE; CHEMOKINES; ENZYME ACTIVATION; HUMANS; INTRACELLULAR SPACE; LIGANDS; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; PROTEIN STRUCTURE, TERTIARY; PROTEIN TRANSPORT; RECEPTORS, CXCR; SEQUENCE DELETION;

EID: 84857915413     PISSN: 13572725     EISSN: 18785875     Source Type: Journal    
DOI: 10.1016/j.biocel.2012.01.007     Document Type: Article

References (41)

1. K. Balabanian, A. Levoye, L. Klemm, B. Lagane, O. Hermine, and J. Harriague Leukocyte analysis from WHIM syndrome patients reveals a pivotal role for GRK3 in CXCR4 signaling J Clin Invest 118 2008 1074 1084 (Pubitemid 351364615)
2. B. Boldajipour, S. Mahabaleshwar, E. Kardash, M. Reichman-Fried, H. Blaser, and S. Minina Control of chemokine-guided cell migration by ligand sequestration Cell 132 2008 463 473 (Pubitemid 351191997)
3. B. Cen, Q. Yu, J. Guo, Y. Wu, K. Ling, and Z. Cheng Direct binding of beta-arrestins to two distinct intracellular domains of the delta opioid receptor J Neurochem 76 2001 1887 1894 (Pubitemid 32221129)
4. L. Cruz-Orengo, D. Holman, D. Dorsey, L. Zhou, P. Zhang, and M. Wright CXCR7 influences leukocyte entry into the CNS parenchyma by controlling abluminal CXCL12 abundance during autoimmunity J Exp Med 208 2011 327 329
5. F. Decaillot, M. Kazmi, Y. Lin, S. Ray-Saha, T. Sakmar, and P. Sachdev CXCR7/CXCR4 heterodimer constitutively recruits {beta}-arrestin to enhance cell migration J Biol Chem 286 2011 32188 32197
6. G. Della Rocca, Y. Mukhin, M. Garnovskaya, Y. Daaka, G. Clark, and L. Luttrell Serotonin 5-HT1A receptor-mediated Erk activation requires calcium/calmodulin-dependent receptor endocytosis J Biol Chem 274 1999 4749 4753
7. S. DeWire, S. Ahn, R. Lefkowitz, and S. Shenoy Beta-arrestins and cell signaling Ann Rev Physiol 69 2007 483 510
8. M. Drake, J. Violin, E. Whalen, J. Wisler, S. Shenoy, and R. Lefkowitz Beta-arrestin-biased agonism at the beta2-adrenergic receptor J Biol Chem 383 2008 5669 5676
9. Z. Fredericks, J. Pitcher, and R. Lefkowitz Identification of the G protein-coupled receptor kinase phosphorylation sites in the human beta2-adrenergic receptor J Biol Chem 271 1996 13796 13803
10. Z. Gaborik, M. Szaszak, L. Szidonya, B. Balla, S. Paku, and K. Catt Beta-arrestin- and dynamin-dependent endocytosis of the AT1 angiotensin receptor Mol Pharmacol 59 2001 239 247 (Pubitemid 32108556)
11. M. Garcia Lopez, A. Aquado Martinez, C. Lamaze, C. Martinez-A, and T. Fischer Inhibition of dynamin prevents CCL2-mediated endocytosis of CCR2 and activation of ERK1/2 Cell Signal 21 2009 1748 1757
12. H. Gerrits, D. van Ingen Schenau, N. Bakker, A. van Disseldorp, A. Strik, and L. Hermens Early postnatal lethality and cardiovascular defects in CXCR7-deficient mice Genesis 46 2008 235 245 (Pubitemid 351961759)
13. K. Hattermann, J. Held-Feindt, R. Lucius, S. Muerkoster, M. Penfold, and T. Schall The chemokine receptor CXCR7 is highly expressed in human glioma cells and mediates antiapoptotic effects Cancer Res 70 2010 3299 3308
14. I. Kalatskaya, Y. Berchiche, S. Gravel, B. Limberg, J. Rosenbaum, and N. Heveker AMD3100 is a CXCR7 ligand with allosteric agonist properties Mol Pharmacol 75 2009 1240 1247
15. A. Levoye, K. Balabanian, F. Baleux, F. Bachelerie, and B. Lagane CXCR7 heterodimerizes with CXCR4 and regulates CXCL12-mediated G protein signaling Blood 113 2009 6085 6093
16. G. Luker, T. Flagg, A. Sha, K. Luker, C. Pica, and C. Nichols MDR1 P-glycoprotein reduces influx of substrates without affecting membrane potential J Biol Chem 276 2001 49053 49060
17. K. Luker, M. Gupta, and G. Luker Imaging CXCR4 signaling with firefly luciferase complementation Anal Chem 80 2008 5565 5573
18. K. Luker, M. Gupta, and G. Luker Bioluminescent CXCL12 fusion protein for cellular studies of CXCR4 and CXCR7 Biotechniques 47 2009 625 632
19. K. Luker, M. Gupta, and G. Luker Imaging chemokine receptor dimerization with firefly luciferase complementation FASEB J 23 2009 823 834
20. K. Luker, M. Gupta, J. Steele, B. Foerster, and G. Luker Imaging ligand-dependent activation of CXCR7 Neoplasia 11 2009 1022 1035
21. K. Luker, L. Mihalko, B. Schmidt, S. Lewin, P. Ray, and D. Shcherbo In vivo imaging of ligand receptor binding with Gaussia luciferase complementation Nat Med 18 2012 172 177
22. K. Luker, J. Steele, L. Mihalko, and G. Luker Constitutive and chemokine-dependent internalization and recycling of CXCR7 in breast cancer cells to degrade chemokine ligands Oncogene 29 2010 4599 4610
23. B. Mazzinghi, E. Ronconi, E. Lazzeri, C. Sagrinati, L. Bellerini, and M. Angelotti Essential but differential role for CXCR4 and CXCR7 in the therapeutic homing of human renal progenitor cells J Exp Med 205 2008 479 790
24. P. McCormick, M. Segarra, P. Gasperini, A.V. Gulino, and G. Tosato Impaired recruitment of Grk6 and β-arrestin 2 causes delayed internalization and desensitization of a WHIM syndrome-associated CXCR4 mutant receptor PLoS ONE 4 2009 e8102
25. Z. Miao, K. Luker, B. Summers, R. Berahovich, M. Bhojani, and A. Rehemtulla CXCR7 (RDC1) promotes breast and lung tumor growth in vivo and is expressed on tumor-associated vasculature Proc Natl Acad Sci USA 104 2007 15735 15740 (Pubitemid 350035369)
26. U. Naumann, E. Cameroni, M. Pruenster, S. Mahabaleshwar, E. Raz, and H. Zerwes CXCR7 functions as a scavenger for CXCL12 and CXCL11 PLoS ONE 5 2010 e9175
27. S. Rajagopal, J. Kim, S. Ahn, S. Craig, C. Lam, and N. Gerard Beta-arrestin- but not G protein-mediated signaling by the decoy receptor CXCR7 Proc Natl Acad Sci USA 107 2010 628 632
28. J. Sanchez-Alcaniz, S. Haege, W. Mueller, R. Pla, F. Mackay, and S. Schulz Cxcr7 controls neuronal migration by regulating chemokine responsiveness Neuron 69 2011 77 90
29. F. Schmidlin, D. Roosterman, and N. Bunnett The third intracellular loop and carboxyl tail of neurokinin 1 and 3 receptors determine interactions with beta-arrestins Am J Physiol Cell Physiol 285 2003 C945 C958
30. S. Shimizu, M. Brown, R. Sengupta, M. Penfold, and O. Meucci CXCR7 protein expression in human adult brain and differentiated neurons PLoS ONE 6 2011 e20680
31. T. Shioda, E. Nakayama, Y. Tanaka, X. Xin, H. Liu, and A. Kawana-Tachikawa Naturally occurring deletional mutation in the C-terminal cytoplasmic tail of CCR5 affects surface trafficking of CCR5 J Virol 75 2001 3462 3468 (Pubitemid 32225909)
32. F. Sierro, C. Biben, L. Martinez-Munoz, M. Mellado, R. Rashohoff, and M. Li Disrupted cardiac development but normal hematopoiesis in mice deficient in the second CXCL12/SDF-1 receptor, CXCR7 Proc Natl Acad Sci USA 104 2007 14759 14764 (Pubitemid 350003216)
33. R. Singh, and B. Lokeshwar The IL-8-regulated chemokine receptor CXCR7 stimulates EGFR signaling to promote prostate cancer growth Cancer Res 71 2011 3268 3277
34. M. Smith, K. Luker, J. Garbow, J. Prior, E. Jackson, and D. Piwnica-Worms CXCR4 regulates growth of both primary and metastatic breast cancer Cancer Res 64 2004 8604 8612 (Pubitemid 39552073)
35. J. Song, S. Cavnar, A. Walker, K. Luker, M. Gupta, and Y. Tung Microfluidic endothelium for studying the intravascular adhesion of metastatic breast cancer cells PLoS ONE 4 2009 e5756
36. A. Tohgo, E. Choy, D. Gesty-Palmer, K. Pierce, S. Laporte, and R. Oakley The stability of the G protein-coupled receptor-beta-arrestin interaction determines the mechanism and functional consequence of ERK activation J Biol Chem 278 2003 6258 6267 (Pubitemid 36800882)
37. Y. Torisawa, B. Mosadegh, T. Bersano-Begey, J. Steele, K. Luker, and G. Luker Microfluidic platform for chemotaxis in gradients formed by CXCL12 source-sink cells Integr Biol (Camb) 2 2010 680 686
38. J. Wang, Y. Shiozawa, J. Wang, Y. Wang, Y. Jung, and K. Pienta The role of CXCR7/RDC1 as a chemokine receptor for CXCL12/SDF-1 in prostate cancer J Biol Chem 283 2008 4283 4294
39. Y. Wang, G. Li, A. Stanco, J. Long, D. Crawford, and G. Potter CXCR4 and CXCR7 have distinct functions in regulating interneuron migration Neuron 69 2011 61 76
40. K. Watanabe, M. Penfold, A. Matsuda, N. Ohyanagi, K. Kaneko, and Y. Miyabe Pathogenic role of CXCR7 in rheumatoid arthritis Arthritis Rheum 62 2010 3211 3220
41. B. Zabel, Y. Wang, S. Lewen, R. Berahovich, M. Penfold, and P. Zhang Elucidation of CXCR7-mediated signaling events and inhibition of CXCR4-mediated tumor cell transendothelial migration by CXCR7 ligands J Immunol 183 2009 3204 3211